Yes, this is something that needs to be addressed.
Justyn is LCK IMO. He’s essentially the face of the company, does all of the interviews (and interviews really well, I might add)…..
Our MD however, on $400k odd a year, and just seems to avoid the cameras (doesn’t interview well, like Justyn does). He’s basically a shadow MD, IMO.
He really is remunerated incredibly well, for an MD that isn’t the face of the company.
We’re moving to the next phase in the company’s development, and the board/management needs to reflect this.
IMO, Phil needs to step down (perhaps a CFO role or something), and the company needs a well known, charismatic MD who has experience with Urea.
The right person in this role is crucial.
They also need to employ someone who can assist with marketing, and liaising with instos/big funds.
Raising at these low levels is becoming a foul habit, particularly given where the company sits fundamentally, with a commodity that’s in a bull market.
At some point ego and hubris need to be pushed to the side, and those at the top need to concede that they are indeed responsible for where the company’s MC is sitting…. And accept that not all of them are suited to their current positions.
All IMO
Cheyne
LCK Price at posting:
15.0¢ Sentiment: Buy Disclosure: Held
